Sculptor Capital’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

Sculptor Capital’s Portfolio LVAC Stock Details LVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-431,260	Closed	-$4.39M	–	768
2022 Q4	$4.39M	Hold	431,260	–	–	0.08%	269
2022 Q3	$4.33M	Hold	431,260	–	–	0.05%	396
2022 Q2	$4.3M	Buy	431,260 +100	+0%	+$999	0.05%	446
2022 Q1	$4.3M	Buy	431,160 +256,158	+146%	+$2.54M	0.03%	471
2021 Q4	$1.72M	Buy	+175,002	New	+$1.73M	0.01%	612

Other funds holding LVAC

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

CCA

Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Quarry LP New York $558M AUM 23.92% 1-Year Est. Return

Sculptor Capital's LVAC Position: Q1 2023 in Review

Sculptor Capital sold out of LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) in Q1 2023, closing a stake of 431,260 shares — an estimated $4.39M sold.

Sculptor Capital first reported a position in LVAC in Q4 2021 and held it in 5 quarters. The position peaked at $4.39M in Q4 2022. 54 funds tracked by Wall St. Rank hold LVAC as of Q1 2023.

Sculptor Capital reported no remaining LAVA Medtech Acquisition Corp. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
Sculptor Capital sold 431,260 LAVA Medtech Acquisition Corp. Class A Common Stock shares in Q1 2023, an estimated $4.39M.
Sculptor Capital first reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock in Q4 2021 and held it in 5 quarters.
Sculptor Capital's LAVA Medtech Acquisition Corp. Class A Common Stock position peaked at $4.39M in Q4 2022.
54 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Class A Common Stock as of Q1 2023.

Based on Sculptor Capital's 13F filing for Q1 2023, filed 16 May 2023.